LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Sun, 17 Oct 2010 15:19:03 -0700
Content-Type:
text/plain
Parts/Attachments:
text/plain (84 lines)
I've heard about the wonders of Diflucan for treating yeast before so I
decided to Google "Diflucan, dangers" and found this:

 

http://www.yourlawyer.com/newsletter/read/48

 

Exerpt:

Granted, yeast infections can be painful, embarrassing and extremely
uncomfortable, yet is any of that serious enough to risk the following
published dangers:

 

 

    * DIFLUCAN has been associated with rare cases of serious hepatic
(liver) toxicity, including fatalities. This danger bears no obvious
relationship to total daily dose, duration of therapy, sex or age of
patient.

    * Anaphylaxis (allergic reaction) in rare cases.

    * Exfoliative skin disorders (detachment and shedding of skin) in rare
cases. In patients with serious underlying diseases, these disorders can be
fatal in rare cases.

    * Kidney problems ranging from mild to failure to death.

    * A 26% incidence of drug related adverse events as opposed to only 16%
for intravaginal agents.

    * Clinically or potentially significant drug interactions between
DIFLUCAN and the following have been observed: Oral hypoglycemics (ex.
glyburide), Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin,
Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, and Tacrolimus.
These interactions may cause reactions such as death, kidney impairment,
blood disorders or chemical imbalance, serious cardiac dysrhythmias, cardiac
"events", nephrotoxicity as well as other, yet unknown, reactions.

 

    * (Based on pregnant animal testing) - Impairment of material weight
gain, abortion, increased placental weights, fetal abnormalities.

    * Although there are no adequate and well controlled studies in pregnant
women, there have been reports of multiple congenital abnormalities in
infants whose mothers were treated for three (3) or more months with high
dosages of DIFLUCAN. Thus, DIFLUCAN should only be used in pregnancy "if the
potential benefit justifies the possible risk to the fetus."

    * Headache.

    * Nausea, vomiting.

    * Abdominal pain.

    * Skin rash.

    * Diarrhea.

    * Not recommended for use by nursing mothers.

    * Seizures, Stevens-Johnson syndrome, alopecia, blood and metabolic
disorders have occurred "under conditions where a causal association is
uncertain."

 


             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome

ATOM RSS1 RSS2